Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to neutralize a broad diversity of SARS-CoV-2 variants. Researchers from Lawrence Livermore National Laboratory (LLNL) ….